Bowel Preparation Before Colonoscopy Clinical Trial
Official title:
Improved Bowel Preparation Method for Colonoscopy Based on Different Risk Stratification:a Multicenter, Endoscopist-blinded Randomized Controlled Trial
| Verified date | December 2022 |
| Source | Renmin Hospital of Wuhan University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The purpose of this study is to evaluate the efficacy of polyethylene glycol(PEG) combined with lactulose for bowel preparation before colonoscopy in low-risk patients and high-risk patients.
| Status | Completed |
| Enrollment | 2028 |
| Est. completion date | August 15, 2021 |
| Est. primary completion date | August 15, 2021 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility | Inclusion Criteria: - Adults undergoing colonoscopy. Exclusion Criteria: - 1.presence of any contraindications for colonoscopy (gastrointestinal obstruction or perforation,severe acute inflammatory bowel disease,toxic megacolon,severe heart failure,unable to swallow,severe heart failure,etc); - 2.Patients with galactosemia; - 3. hypersensitivity to any of the ingredients; - 4.Pregnancy or lactation; - 5.Use of lactulose,prokinetic agents or purgatives within 7 days; - 6.Unwilling to sign informed consent. |
| Country | Name | City | State |
|---|---|---|---|
| China | Renmin Hospital of Wuhan University | Wuhan | Hubei |
| Lead Sponsor | Collaborator |
|---|---|
| Renmin Hospital of Wuhan University | Hubei Hospital of Traditional Chinese Medicine, The General Hospital of Central Theater Command, The Third People's Hospital of Hubei Province, Tian You Hospital Affiliated to Wuhan University of Science and Technology, Wuhan Central Hospital, Wuhan Puai Hospital, Wuhan Puren Hospital, Wuhan Red Cross Hospital, Wuhan Third Hospital |
China,
ASGE Standards of Practice Committee, Saltzman JR, Cash BD, Pasha SF, Early DS, Muthusamy VR, Khashab MA, Chathadi KV, Fanelli RD, Chandrasekhara V, Lightdale JR, Fonkalsrud L, Shergill AK, Hwang JH, Decker GA, Jue TL, Sharaf R, Fisher DA, Evans JA, Foley K, Shaukat A, Eloubeidi MA, Faulx AL, Wang A, Acosta RD. Bowel preparation before colonoscopy. Gastrointest Endosc. 2015 Apr;81(4):781-94. doi: 10.1016/j.gie.2014.09.048. Epub 2015 Jan 14. No abstract available. — View Citation
Bai Y, Fang J, Zhao SB, Wang D, Li YQ, Shi RH, Sun ZQ, Sun MJ, Ji F, Si JM, Li ZS. Impact of preprocedure simethicone on adenoma detection rate during colonoscopy: a multicenter, endoscopist-blinded randomized controlled trial. Endoscopy. 2018 Feb;50(2):128-136. doi: 10.1055/s-0043-119213. Epub 2017 Oct 6. — View Citation
Hassan C, East J, Radaelli F, Spada C, Benamouzig R, Bisschops R, Bretthauer M, Dekker E, Dinis-Ribeiro M, Ferlitsch M, Fuccio L, Awadie H, Gralnek I, Jover R, Kaminski MF, Pellise M, Triantafyllou K, Vanella G, Mangas-Sanjuan C, Frazzoni L, Van Hooft JE, Dumonceau JM. Bowel preparation for colonoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2019. Endoscopy. 2019 Aug;51(8):775-794. doi: 10.1055/a-0959-0505. Epub 2019 Jul 11. — View Citation
Kang X, Zhao L, Zhu Z, Leung F, Wang L, Wang X, Luo H, Zhang L, Dong T, Li P, Chen Z, Ren G, Jia H, Guo X, Pan Y, Guo X, Fan D. Same-Day Single Dose of 2 Liter Polyethylene Glycol is Not Inferior to The Standard Bowel Preparation Regimen in Low-Risk Patients: A Randomized, Controlled Trial. Am J Gastroenterol. 2018 Apr;113(4):601-610. doi: 10.1038/ajg.2018.25. Epub 2018 Mar 13. — View Citation
Lu J, Cao Q, Wang X, Pu J, Peng X. Application of Oral Lactulose in Combination With Polyethylene Glycol Electrolyte Powder for Colonoscopy Bowel Preparation in Patients With Constipation. Am J Ther. 2016 Jul-Aug;23(4):e1020-4. doi: 10.1097/MJT.0000000000000351. — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Boston Bowel Preparation Scale | Cleanliness of the colon during colonoscopy will be evaluated by the Boston Bowel Preparation Scale which is a 4-point scoring system applied to each of 3 broad regions of the colon: the right side, the transverse section, and the left side. The total BBPS score ranged from 0 to 9. If total BostonBowel Preparation Score =6 with each segmental BBPS=2, we regard it as adequate bowel preparation. | during colonoscopy | |
| Secondary | Adenoma Detection Rate | Diagnosis was confirmed by histologic examination | 2 days | |
| Secondary | Rate of adverse events | adverse events, such as vomiting, nausea, headache, abdominal distention,abdominal pain. | 2 days | |
| Secondary | Cecal intubation rate | Colonoscopy reaches cecal region. | during colonoscopy | |
| Secondary | Cecal intubation time | Colonoscopy reaches cecal region. | during colonoscopy | |
| Secondary | Withdrawal time | The time from the cecum to the anus, but excluded time for biopsy performance or removal of polyps. | during colonoscopy | |
| Secondary | defecation frequency | Frequency of bowel movement. | 2 days | |
| Secondary | Willingness to repeat bowel preparation | The number of patients have a willingness to undergo a repeated bowel preparation if needed. | 2 days |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01984008 -
A Study of the Efficacy and Safety of Bowklean and Klean-Prep With Dulcolax for the Bowel Preparation Prior Colonoscopy
|
Phase 3 | |
| Recruiting |
NCT05498714 -
Improved Bowel Cleansing Method for Colonoscopy Based on High Risk Population of Bowel Preparation
|
N/A | |
| Completed |
NCT01745835 -
Comparison Between 2L Coolprep® and Combination of 1L Coolprep® and Bisacodyl as Bowel Preparation
|
Phase 3 | |
| Completed |
NCT02910440 -
A Safety and Efficacy Study of DCL-101 Compared to GoLYTELY
|
Phase 2 | |
| Recruiting |
NCT05054036 -
MoviPrep® Versus GoLYTELY® Bowel Preparation in Hospitalized Patients Undergoing Colonoscopy
|
Phase 4 | |
| Recruiting |
NCT03106922 -
A Trial to Evaluate the Efficacy and Safety of PMF104 Compared to a Conventional PEG-electrolyte Solution in Children
|
Phase 3 |